July 24, 2006 mcfadyena

Elaprase approved by the FDA

Elaprase, the drug that Trey needs has been approved by the FDA. Now the battle really begins to get Trey the treatment here in Canada. Because Health Canada has not approved Elaprase, and Canada does not have an Orphan Drug Policy (a policy regarding treatments that are needed by very very few people), this will be an uphill battle.
Our doctor, Dr. Sylvia Stockler, has applied to the government for Special Access for Trey. We should hear about this in the coming weeks. If this is granted, it becomes a matter of finding someone to fund the treatment – which will run in the hundred of thousands per year. Funding could be provided by the hospital, the pharmaceutical company or the government.
Once this is in place, Trey will have access to Enzyme Replacement Therapy.


We want to hear from you! Send us your story so we can share it with the world. Every person and family battling Hunter Syndrome has a unique story to tell - one of bravery, resilience, and perseverance. We'll share all stories online here and on our social media feeds!